This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Raymond James Financial, Inc. (RJF) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
LPL Financial Holdings Inc. (LPLA) Up 2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
LPL Financial Holdings Inc. (LPLA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Raymond James Financial (RJF) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wall Street Analysts Think Raymond James Financial, Inc. (RJF) Could Surge 26%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 26.5% upside potential for Raymond James Financial, Inc. (RJF). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Why Raymond James Financial, Inc. (RJF) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Raymond James Financial (RJF) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wall Street Analysts See a 33% Upside in Raymond James Financial, Inc. (RJF): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 32.9% in Raymond James Financial, Inc. (RJF). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Raymond James (RJF) Q3 Earnings Lag on Weak IB, High Provisions
by Zacks Equity Research
Subdued IB performance, increased provisions and higher costs hurt Raymond James' (RJF) fiscal Q3 earnings. Yet, rising rates, higher loan demand and the prior acquisitions offer some support.
Moelis & Company (MC) Q2 Earnings Beat, Revenues & Costs Dip
by Zacks Equity Research
Moelis & Company (MC) records a decline in revenues in the second quarter of 2022. The liquidity position remains strong.
Raymond James Financial, Inc. (RJF) Q3 Earnings Miss Estimates
by Zacks Equity Research
Raymond James Financial, Inc. (RJF) delivered earnings and revenue surprises of -0.62% and 4.74%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
UMB Financial (UMBF) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
UMB (UMBF) delivered earnings and revenue surprises of 50.53% and 18.04%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Poor Investment Banking to Hurt Raymond James (RJF) Q3 Earnings
by Zacks Equity Research
Driven by higher interest rates and loan growth, Raymond James (RJF) is expected to have recorded an increase in interest income in third-quarter fiscal 2022 (ended Jun 30).
Why is Q2 Earnings Beat Less Likely for Ameriprise (AMP)?
by Zacks Equity Research
Improved advisor productivity is expected to have supported Ameriprise's (AMP) asset growth to some extent in the second quarter of 2022.
Why is an Earnings Beat Less Likely for Invesco (IVZ) in Q2?
by Zacks Equity Research
Despite the expected decline in asset balances, Invesco's (IVZ) second-quarter 2022 performance fee is likely to have improved.
Raymond James Financial, Inc. (RJF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Raymond James Financial, Inc. (RJF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Interactive Brokers (IBKR) Stock Declines on Q2 Earnings Miss
by Zacks Equity Research
Interactive Brokers (IBKR) records a y/y fall in revenues in the second quarter of 2022. Higher expenses act as another headwind.
Schwab (SCHW) Up as Q2 Earnings Beat Estimates, Revenues Rise
by Zacks Equity Research
Higher interest rates, a decline in fee waivers and rising brokerage account numbers support Schwab's (SCHW) Q2 earnings.
The Zacks Analyst Blog Highlights JPMorgan Chase, M&T Bank, Raymond James Financial, Arch Capital Group, and Everest Re Group.
by Zacks Equity Research
JPMorgan Chase, M&T Bank, Raymond James Financial, Arch Capital Group, and Everest Re Group are part of Zacks top Analyst Blog.
Fed Likely to Pursue Ultra-Hawkish Policies in July: 5 Picks
by Nalak Das
We have narrowed our search to five financial stocks with strong long-term growth potential. These are: MTB, JPM, RJF, ACGL and RE.
Zacks Industry Outlook Highlights Raymond James Financial, Evercore and Cowen
by Zacks Equity Research
Raymond James Financial, Evercore and Cowen have been highlighted in this Industry Outlook article.
3 Investment Bank Stocks to Buy Despite Industry Challenges
by Swayta Shah
The tough operating environment weighs on the Zacks Investment Bank industry, which will hurt revenue growth. Yet, Raymond James (RJF), Evercore (EVR) and Cowen (COWN) are worth investing in for long-term gains.
Moelis & Company (MC) Q1 Earnings Beat, Expenses Rise Y/Y
by Zacks Equity Research
Rise in revenues and solid liquidity position support Moelis & Company's (MC) Q1 results.
Raymond James (RJF) Q2 Earnings Miss on Subdued IB, Provisions
by Zacks Equity Research
Dismal IB performance and higher bank loan provision for credit losses hurt Raymond James' (RJF) fiscal Q2 earnings, while higher interest income and loan growth offer some support.
Raymond James Financial, Inc. (RJF) Misses Q2 Earnings Estimates
by Zacks Equity Research
Raymond James Financial, Inc. (RJF) delivered earnings and revenue surprises of -4.32% and 2%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Weak Investment Banking to Hurt Raymond James (RJF) Q2 Earnings
by Zacks Equity Research
Subdued IB business and rise in expenses are expected to have hampered Raymond James' (RJF) fiscal Q2 earnings. Decent trading performance and rise in loan demand are likely to have offered support.